Previous Article | Next Article ![]()
Journal of Clinical Microbiology, November 2000, p. 4026-4033, Vol. 38, No. 11
Servicio de Bacteriología1
and Servicio de Parasitología,4
Centro Nacional de Microbiología, Instituto de Salud
Carlos III, 28220 Majadahonda, Madrid, Servicio de
Investigación y Mejora Agraria (AZTI-SIMA), Departamento de
Agricultura, Gobierno Vasco, 48160 Derio,
Vizcaya,2 and Consejería de
Salud, Consumo y Bienestar Social del Gobierno de la Rioja, 26071 Logroño,3 Spain
Received 25 May 2000/Accepted 29 August 2000
Fifteen Borrelia burgdorferi sensu lato isolates from
questing ticks and skin biopsy specimens from erythema migrans patients in three different areas of Spain were characterized. Four different genospecies were found (nine Borrelia garinii, including
the two human isolates, three B. burgdorferi sensu stricto,
two B. valaisiana, and one B. lusitaniae),
showing a diverse spectrum of B. burgdorferi sensu lato
species. B. garinii isolates were highly variable in terms
of pulsed-field gel electrophoresis pattern and OspA serotype, with
four of the seven serotypes described. One of the human isolates was
OspA serotype 5, the same found in four of seven tick isolates. The
second human isolate was OspA serotype 3, which was not present in
ticks from the same area. Seven B. garinii isolates were
able to disseminate through the skin of C3H/HeN mice and to cause
severe inflammation of joints. One of the two B. valaisiana
isolates also caused disease in mice. Only one B. burgdorferi sensu stricto isolate was recovered from the urinary
bladder. One isolate each of B. valaisiana and B. lusitaniae were not able to disseminate through the skin of mice
or to infect internal organs. In summary, there is substantial
diversity in the species and in the pathogenicity of B. burgdorferi sensu lato in areas in northern Spain where Lyme
disease is endemic.
0095-1137/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Molecular and Pathogenic Characterization of Borrelia
burgdorferi Sensu Lato Isolates from Spain
*
Corresponding author. Mailing address: Servicio de
Bacteriología, Centro Nacional de
Microbiología-Instituto de Salud Carlos III,
28220-Majadahonda, Madrid, Spain. Phone: (34) 91 509 7901. Fax:
(34) 91 509 7966. E-mail: panda{at}isciii.es.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|